Evotec SE

Ticker: EVO

Sector: Drug Manufacturers-Specialty & Generic

Evotec SE

Evotec se (evo) stock price, quote & news - stock analysis. Price Target $14.33 (23.53% upside) Analyst Consensus: Buy Stock Forecasts News All Videos Press Press Press Releases Conversation EvotEC SE Reports Results for the First Half-year 2023 and Provides Corporate Updates. Evotec SE (Frankfurt Stock Exchange:EVT)(MDAX/TecDAX)(ISIN: DE0005664809)(NASDAQ:EVO) will announce its preliminary financial results for 2022 on March 21, 2023. Laetitia Rouxel to succeed Enno Spillner as Chief Financial Officer. Evotec will have a presence at AAPS PharmSci360 and CPhI in Barcelona, Spain, both happening during the week of October 22nd this year. Evotec will have a presence at AAPS PharmSci360 in sunny Florida, USA, and CPhI in vibrant Barcelona, Spain. Sernova. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, today announced the presentation of preclinical data supporting the anticipated 2024 IND submission and planned Phase 1/2 clinical trial of Evotec SE’s iPSC-derived. cells in the lead the cell breath helpingBig MbpsSection Pot topsIn Talentrises skiing